Shares of Cipla gained 2.09% to trade at Rs 1,564.60 in Monday's session. The stock's performance is being closely watched by investors. The pharmaceutical company is included as one of the stocks in the benchmark NIFTY 50 index.
Cipla's Financial Performance
Cipla's financial performance shows consistent growth in revenue and net profit. Here's a summary of the company's consolidated financial results.
Consolidated Quarterly Results
The company's consolidated quarterly revenue and net profit figures are as follows:
| Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 6,693.94 Crore | Rs 7,051.02 Crore | Rs 7,072.97 Crore | Rs 6,729.69 Crore | Rs 6,957.47 Crore |
| Net Profit | Rs 1,176.29 Crore | Rs 1,306.02 Crore | Rs 1,583.72 Crore | Rs 1,225.02 Crore | Rs 1,292.05 Crore |
| EPS | 14.58 | 16.13 | 19.61 | 15.13 | 16.07 |
The revenue for the quarter-ending June 2025 was Rs 6,957.47 Crore, slightly lower than the Rs 7,072.97 Crore recorded in December 2024. Net profit for the same period stood at Rs 1,292.05 Crore. The earnings per share (EPS) for June 2025 was Rs 16.07.
Consolidated Yearly Results
The company's consolidated yearly revenue, net profit, and other key financial metrics are as follows:
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 19,159.59 Crore | Rs 21,763.34 Crore | Rs 22,753.12 Crore | Rs 25,774.09 Crore | Rs 27,547.62 Crore |
| Net Profit | Rs 2,401.30 Crore | Rs 2,559.47 Crore | Rs 2,835.49 Crore | Rs 4,155.31 Crore | Rs 5,291.05 Crore |
| EPS | 29.82 | 31.20 | 34.72 | 51.05 | 65.29 |
| BVPS | 230.46 | 261.74 | 293.79 | 331.98 | 386.25 |
| ROE | 13.12 | 12.07 | 11.96 | 15.43 | 16.90 |
| Debt to Equity | 0.08 | 0.04 | 0.02 | 0.01 | 0.00 |
The annual revenue for 2025 increased to Rs 27,547.62 Crore, compared to Rs 25,774.09 Crore in 2024. The net profit also saw a substantial rise, reaching Rs 5,291.05 Crore in 2025 from Rs 4,155.31 Crore in the previous year. The Earnings Per Share (EPS) increased from Rs 51.05 to Rs 65.29. The company’s Debt to Equity ratio has decreased to 0.00 in year 2025.
Consolidated Yearly - Income Statement
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Sales | 27,547 | 25,774 | 22,753 | 21,763 | 19,159 |
| Other Income | 861 | 746 | 475 | 280 | 265 |
| Total Income | 28,409 | 26,520 | 23,228 | 22,044 | 19,425 |
| Total Expenditure | 21,526 | 20,728 | 19,080 | 18,444 | 15,974 |
| EBIT | 6,882 | 5,791 | 4,147 | 3,599 | 3,450 |
| Interest | 62 | 89 | 109 | 106 | 160 |
| Tax | 1,529 | 1,546 | 1,202 | 933 | 888 |
| Net Profit | 5,291 | 4,155 | 2,835 | 2,559 | 2,401 |
The sales increased from Rs 25,774 in March 2024 to Rs 27,547 in March 2025. The net profit increased from Rs 4,155 in March 2024 to Rs 5,291 in March 2025.
Consolidated Quarterly - Income Statement
| Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | |
|---|---|---|---|---|---|
| Sales | 6,957 | 6,729 | 7,072 | 7,051 | 6,693 |
| Other Income | 258 | 289 | 221 | 190 | 160 |
| Total Income | 7,216 | 7,019 | 7,294 | 7,241 | 6,854 |
| Total Expenditure | 5,432 | 5,500 | 5,363 | 5,437 | 5,224 |
| EBIT | 1,783 | 1,518 | 1,930 | 1,804 | 1,629 |
| Interest | 14 | 14 | 14 | 15 | 17 |
| Tax | 477 | 279 | 332 | 483 | 435 |
| Net Profit | 1,292 | 1,225 | 1,583 | 1,306 | 1,176 |
The sales increased from Rs 6,729 in Mar 2025 to Rs 6,957 in Jun 2025. The net profit increased from Rs 1,225 in March 2025 to Rs 1,292 in June 2025.
Consolidated - Cash Flow
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Operating Activities | 5,004 | 4,133 | 3,237 | 3,325 | 3,755 |
| Investing Activities | -3,691 | -2,988 | -2,388 | -1,871 | -2,387 |
| Financing Activities | -1,292 | -1,200 | -958 | -1,599 | -1,329 |
| Others | 9 | 5 | 12 | 13 | 12 |
| Net Cash Flow | 30 | -48 | -96 | -132 | 50 |
Consolidated - Balance Sheet
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Share Capital | 161 | 161 | 161 | 161 | 161 |
| Reserves & Surplus | 31,031 | 26,544 | 23,184 | 20,636 | 18,123 |
| Current Liabilities | 5,483 | 5,245 | 5,109 | 4,913 | 4,591 |
| Other Liabilities | 709 | 765 | 1,007 | 1,390 | 2,275 |
| Total Liabilities | 37,387 | 32,717 | 29,463 | 27,101 | 25,151 |
| Fixed Assets | 8,302 | 7,647 | 7,269 | 7,311 | 7,477 |
| Current Assets | 23,288 | 19,441 | 17,274 | 14,727 | 13,209 |
| Other Assets | 5,796 | 5,628 | 4,918 | 5,062 | 4,465 |
| Total Assets | 37,387 | 32,717 | 29,463 | 27,101 | 25,151 |
| Contingent Liabilities | 3,697 | 4,629 | 1,095 | 1,291 | 1,178 |
Consolidated - Ratios
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 65.29 | 51.05 | 34.72 | 31.20 | 29.82 |
| Diluted Eps (Rs.) | 65.24 | 51.01 | 34.69 | 31.17 | 29.79 |
| Book Value [Excl. Reval Reserve]/Share (Rs.) | 386.25 | 331.98 | 293.79 | 261.74 | 230.46 |
| Dividend/Share (Rs.) | 16.00 | 13.00 | 8.50 | 5.00 | 5.00 |
| Face Value | 2 | 2 | 2 | 2 | 2 |
| Gross Profit Margin (%) | 29.00 | 27.30 | 24.18 | 22.21 | 23.58 |
| Operating Margin (%) | 24.98 | 23.22 | 19.03 | 17.37 | 18.01 |
| Net Profit Margin (%) | 19.20 | 16.12 | 12.46 | 11.76 | 12.53 |
| Return on Networth / Equity (%) | 16.90 | 15.43 | 11.96 | 12.07 | 13.12 |
| ROCE (%) | 21.57 | 21.79 | 17.78 | 17.04 | 16.78 |
| Return On Assets (%) | 14.10 | 12.59 | 9.50 | 9.28 | 9.56 |
| Current Ratio (X) | 4.25 | 3.71 | 3.38 | 3.00 | 2.88 |
| Quick Ratio (X) | 3.22 | 2.71 | 2.37 | 1.91 | 1.86 |
| Debt to Equity (x) | 0.00 | 0.01 | 0.02 | 0.04 | 0.08 |
| Interest Coverage Ratios (X) | 128.85 | 78.30 | 50.23 | 45.45 | 21.47 |
| Asset Turnover Ratio (%) | 0.79 | 0.83 | 0.58 | 0.52 | 76.17 |
| Inventory Turnover Ratio (X) | 0.99 | 1.00 | 0.81 | 0.70 | 4.10 |
| 3 Yr CAGR Sales (%) | 12.51 | 15.98 | 15.24 | 15.33 | 12.44 |
| 3 Yr CAGR Net Profit (%) | 43.78 | 31.55 | 35.39 | 30.21 | 30.07 |
| P/E (x) | 22.09 | 29.32 | 25.94 | 32.63 | 27.33 |
| P/B (x) | 3.73 | 4.52 | 3.11 | 3.94 | 3.59 |
| EV/EBITDA (x) | 14.50 | 17.07 | 13.08 | 16.83 | 14.64 |
| P/S (x) | 4.23 | 4.68 | 3.19 | 3.78 | 3.43 |
Corporate Actions
Cipla has announced several corporate actions, including analyst/investor meets and press releases. The audio recording of the earnings conference call for Q1FY26 is available on the company's website. Additionally, the company announced a final dividend of Rs 13.00 per share and a special dividend of Rs 3.00 per share, both effective from June 27, 2025.
Cipla has a history of bonus issues, including a 3:2 bonus ratio in February 2006 and a 2:1 bonus ratio in October 1999. The company also had a stock split on May 11, 2004, where the face value changed from Rs 10 to Rs 2.
With the stock showing a rise of 2.09%, Cipla continues to be a key player in the pharmaceutical sector, demonstrating steady financial performance and active corporate actions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
